Literature DB >> 10319949

Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.

K Y Ryu1, M E Senokozlieff, P A Smanik, M G Wong, A E Siperstein, Q Y Duh, O H Clark, E L Mazzaferri, S M Jhiang.   

Abstract

The sodium iodide symporter (NIS) is the plasma membrane protein that mediates active iodide uptake into thyroid follicular cells. To investigate whether human NIS (hNIS) mRNA levels in papillary thyroid carcinomas (PCs) correlate with the ability of tumors to concentrate radioiodide, we developed a reverse transcription-competitive polymerase chain reaction (RT-cPCR) method to quantify the hNIS mRNA levels in thyroid tissues. We studied 7 normal thyroid tissues, 8 PCs, and 1 follicular adenoma. hNIS mRNA levels in PCs were generally lower than those found in normal thyroid tissues. The reduced radioiodide concentrating activity of PCs is due, at least in part, to the reduced expression and/or the decreased stability of hNIS mRNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319949     DOI: 10.1089/thy.1999.9.405

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

Review 1.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas.

Authors:  S J Lee; K-C Choi; J P Han; Y-E Park; M G Choi
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

3.  A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.

Authors:  Vicki E Smith; Martin L Read; Andrew S Turnell; Rachel J Watkins; John C Watkinson; Greg D Lewy; Jim C W Fong; Sally R James; Margaret C Eggo; Kristien Boelaert; Jayne A Franklyn; Christopher J McCabe
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

4.  Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.

Authors:  Séverine Trouttet-Masson; Samia Selmi-Ruby; Françoise Bernier-Valentin; Valérie Porra; Nicole Berger-Dutrieux; Myriam Decaussin; Jean-Louis Peix; Agnès Perrin; Claire Bournaud; Jacques Orgiazzi; Françoise Borson-Chazot; Brigitte Franc; Bernard Rousset
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

5.  Identification of benign and malignant thyroid nodules by in vivo iodine concentration measurement using single-source dual energy CT: A retrospective diagnostic accuracy study.

Authors:  Shun-Yu Gao; Xiao-Yan Zhang; Wei Wei; Xiao-Ting Li; Yan-Ling Li; Min Xu; Ying-Shi Sun; Xiao-Peng Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 6.  Radioactive Iodine Therapy and Glucose Tolerance.

Authors:  Roghaieh Samadi; Babak Shafiei; Fereidoun Azizi; Asghar Ghasemi
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.